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Abstract
Acinetobacter baumannii has been identified by the Infectious Diseases Society of America as one of the six pathogens that
cause majority of hospital infections. Increased resistance of A. baumannii even to the latest generation of b-lactams like
carbapenem is an immediate threat to mankind. As inner-membrane fraction plays a significant role in survival of
A. baumannii, we investigated the inner-membrane fraction proteome of carbapenem-resistant strain of A. baumannii using
Differential In-Gel Electrophoresis (DIGE) followed by DeCyder, Progenesis and LC-MS/MS analysis. We identified 19 over-
expressed and 4 down-regulated proteins (fold change.2, p,0.05) in resistant strain as compared to reference strain. Some
of the upregulated proteins in resistant strain and their association with carbapenem resistance in A. baumannii are: i) b-
lactamases, AmpC and OXA-51: cleave and inactivate carbapenem ii) metabolic enzymes, ATP synthase, malate
dehydrogenase and 2-oxoglutarate dehydrogenase: help in increased energy production for the survival and iii) elongation
factor Tu and ribosomal proteins: help in the overall protein production. Further, entry of carbapenem perhaps is limited by
controlled production of OmpW and low levels of surface antigen help to evade host defence mechanism in developing
resistance in A. baumannii. Present results support a model for the importance of proteins of inner-membrane fraction and
their synergistic effect in the mediation of resistance of A. baumannii to carbapenem.
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Introduction
Acinetobacter baumannii is a non-motile, Gram negative bacteria
known to cause a number of hospital-acquired (nosocomial)
infections including pneumonia, urinary tract infections particu-
larly, amongst patients in the intensive care units, neonatal units
and neurosurgical wards. Infections caused by A. baumannii, have
increased substantially in the last decade and account for about
10% of total bacterial infections [1–4]. However, in India,
prevalence of A. baumannii is about 20%, making it one of the
most notorious gram negative bacteria [5]. The alarming rate
(26%) at which A. baumannii is gradually increasing is of great
concern [6]. Infections caused by A. baumannii represent an
important source of morbidity, mortality and increased costs
[7,8,1].
A. baumannii has acquired resistance to most of these antibiotics
all over the world which is a potential hazard in the treatment. In
other words, the availability of effective antibiotics to treat
A. baumannii is restricted due to rapid increase in the drug
resistance of A. baumannii [9,1,2]. Carbapenems including imipen-
em, meropenem and doripenem were identified as alternate
therapeutics for A. baumannii and are still the most important
options for serious infections caused by multidrug-resistant
A. baumannii. However, by using versatile and robust mechanisms,
A. baumannii acquired resistance even to the latest carbapenems.
This can be understood by looking at the resistant rate to
carbapenem which was only 2% in early 1990’s has increased to
71% by 2008 [10] and is still increasing. Therefore, A. baumannii
infections are increasingly becoming difficult to eradicate due to
high-level of resistance as a result of both intrinsic and acquired
mechanisms.
A. baumannii is known to utilise and activate a number of
mechanisms in developing resistance which include, altering
outer membrane proteins (to decrease the permeability), increas-
ing production of b-lactamases (to hydrolyze b-lactam), alter-
ations in penicillin binding proteins (to facilitate cell wall
synthesis) and activate production of efflux pumps [11–16]. It
has been reported that antibiotic resistance in A. baumannii is
highly associated with membrane proteins [17]. Differential
production of membrane proteins in susceptible and highly
resistant strains of A. baumannii from different parts of the world
clearly shows its strong association with the emergence of the
resistance phenotype [17–20]. Inner membrane fraction proteins
(IMFPs) are essential for energy production, metabolic activities
and cell signalling etc. Most of the studies carried out on
membrane proteomics of A. baumannii focused on the outer
membrane [21,11]. However, laboratory/artificially induced
imipenem resistance was studied by Yun et al in plasma
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membrane proteomics on resistant strain of A. baumannii using
conventional 2D electrophoresis [17]. However, there are no
report available on IMFPs of clinical isolates from hospital using
Differential In-Gel Electrophoresis (DIGE), a highly sensitive
fluorescence based method. Therefore, present study is an
attempt to identify differently expressed IMF proteins of
A. baumannii in three clinical isolates (with different resistance
levels) from our hospital by using DIGE-based proteomic
approach.
Materials and Methods
Reagents
MacConkey agar and Muller Hinton agar were purchased from
Himedia Laboratories Ltd., India and LB media was from
Pronadisa Laboratories, Spain. Urea, thiourea, Tris-HCl, NaCl
and glycine were from Merck, India; N-lauroyl-sarcosine and
ammonium bicarbonate (mass spectrometry grade) were from
Sigma Chemical Co., U.S.A. Hydrochloric acid, glacial acetic
acid, glycerol, and methanol were from Qualigens, India.
Acrylamide, bisacrylamide, ammonium persulphate, TEMED,
SDS, EDTA, Coomassie Brilliant Blue, b-mercaptoethanol and
bromophenol blue were obtained from Bio-Rad Laboratories,
U.S.A. Mass spectrometry grade trypsin was from Promega,
U.S.A. Immobiline dry strips, pharmalytes, dry strip cover fluid,
dithiothreitol (DTT), iodoacetamide and fluorescent dyes (Cy2,
Cy3 and Cy5) were purchased from GE Health Care, Singapore.
Dimethylformamide (HPLC grade) was from Spectrochem, India.
CHAPS, HPLC grade acetonitrile (ACN) and proteomic grade
water were purchased from G. Biosciences, U.S.A. All other
routine chemicals obtained from Merck, India, were of analytical
grade.
Bacterial Strains and Minimal Inhibitory Concentration
Determination
The reference (susceptible) strain ATCC 19606 and 25 clinical
strains of A. baumannii were collected from the Department of
Microbiology, All India Institute of Medical Sciences, New Delhi.
Various biochemical tests like Gram staining, catalase test, citrate
test, triple sugar iron agar test, urease test, motility test, indole test
and temperature sensitive test were used for confirmation of strains
of A. baumannii for the present study [22]. The Minimal inhibitory
concentrations of ATCC and 25 clinical strains of A. baumannii
were determined for imipenem. ATCC19606 and three carbape-
nem resistant strains (high resistant RS307, intermediate resistant
RS122 and low resistant RS259) of A. baumannii were selected for
present study.
Inner Membrane Faction Proteins (IMFPs) Extraction
Total membrane proteins were extracted according to our
previously described method [11]. The pellet containing the total
membrane fraction was washed and resuspended in 2% Sarkosyl
buffer (N-laurylsarkosine in Tris-HCl, pH 7.5) which solubilise the
inner membrane [23]. After sarkosyl treatment, sample was
subjected to ultracentrifugation at 100,000 g for 30 min. The inner
membrane fraction proteins (IMFPs) were separated out as
supernatant which contain ‘‘inner membrane proteins’’ and
‘‘periplasmic proteins’’ and they were stored at 270uC. However,
it may be mentioned that a small protein fractions in IMFPs may
be derived from cytoplasm and outer membrane which is
unavoidable [24]. ATCC19606, RS307, RS122 and RS259 of
A. baumannii were grown three times independently under condi-
tions explained above and its IMFPs were extracted and stored at
270uC.
Differential In-Gel Electrophoresis (DIGE)
50 mg of total IMFPs either from native or RS307 was labeled
with the 200 pmol of fluorescent dyes Cy3 or Cy5 separately.
One-sixth fraction of protein sample from each strain was pooled
and labeled with Cy2. Proteins labeled with Cy2 acts as internal
standard [25]. Protein labeling was performed using similar
method published in our previous paper [11]. The final volume of
reaction mixture was adjusted to 250 mL using rehydration buffer
(7 M urea, 2 M thio-urea, 2% CHAPS, 0.7 mg of DTT, and
1.25 mL of IPG buffer). Rehydration was performed for 16 h in
the dark with 13 cm, 4–7 pH IPG strip. Similar experiments of
DIGE were also performed with ATCC and RS122 or RS259.
Two-Dimensional Gel Electrophoresis
In 2D gel electrophoresis, isoelectric focusing (IEF) was done on
Ettan IPGphor 3 IEF system and SDS-PAGE analysis were
carried out in SE 600 Ruby gel apparatus (GE Healthcare).
Rehydrated IPG strip was subjected to isoelectric focusing for
25000 VhT. After IEF, strips were equilibrated in 2.5 mL of SDS-
equilibration buffer (50 mM Tris-HCl (pH 8.8), 6 M urea,30%
glycerol, 2% SDS, and 0.02% bromophenol blue) containing first
0.05% DTT for 15 minute and then with SDS-equilibration buffer
containing 1.25% iodoacetamide for 15 minute. Second-dimen-
sion electrophoresis was run on a 12% polyacrylamide gel at 4uC
with 15 mA for 30 min and then at 30 mA for both the strips,
until the bromophenol blue came out of the gel.
Image Acquisition
DIGE gels were scanned for Cy2, Cy3 and Cy5 fluorescence
labeled proteins using a Typhoon TRIO Variable Mode Imager
(GE Healthcare). Cy2 images were scanned using 488 nm
excitation and 520BP40 emission filter; Cy3 images were scanned
using 532 nm excitation and 580BP30 emission filter; Cy5 images
were scanned using 633 nm excitation and 670BP30 emission
filter. All gels were scanned with a PMT of 600. Images were
cropped using Image-Quant version 7.0 (GE Healthcare) to
remove extra areas to the gel image. The final protein levels were
determined by the DeCyder software version 7.0 (GE Healthcare)
and Progenesis Same Spots v3.2 (Nonlinear Dynamics).
Statistical Analysis
Replicate gels were used to calculate average abundance
differences and Student’s t-test p-values for each protein across
the three replica gels.
DeCyder. Gel images were processed by DeCyder Differ-
ential Analysis (DIA) using default setting. The estimated number
of spots for each co-detection procedure was set to 1500. The
spots on gels were co-detected automatically as 2DE DIGE
image pairs, which intrinsically link a sample to its in-gel
standard. Differential protein production between two samples in
the gel was based on the ratio of standardized log abundance of
the Cy3 versus Cy5 spot volume over the Cy2 spot volume.
Initially, all DIA workspaces were imported to Biological
Variance Analysis (BVA) workspace and the experimental setup
and relationship between samples were assigned in the BVA
workspace. Each individual image of Cy3 gel or Cy5 gel was
assigned an experimental condition, either native ATCC or
resistant strain according to the labeling. All Cy2 images were
classified as internal standards and were used for gel-to-gel
matching of the standard spot maps in all gel images. The gel
Proteomics of Membrane Fraction of A. baumannii
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Matching between gels was performed utilizing the in-gel
standard from each image pair. Matching was further improved
by land marking and manually confirming potential spots of
interest. The degree of difference in standardized abundance
between two protein spot groups is expressed as average ratio
(fold change). A fold change with a threshold value of minimum
2-fold increase or decrease was used. Student t test was
performed for every matched spot-set, comparing the average
and standard deviation of protein abundance for a given spot.
Therefore, proteins which had higher value than 2-fold change
and also with a significant p-value (e0.05) were considered in the
present study for identification [26,27].
Progenesis same spots. The gel image analysis was also
performed using Progenesis Same Spots v3.2 image analysis
software. The image realigning, noise filtering, and spots
segmentation were carried out using default setting as outlined
in the software manual [28,29]. Automatic analysis was performed
on all the aligned images using the analysis wizard. The aligned
images were grouped into ATCC and resistant strain to reflect the
biological grouping and the statistically ranked list of spots were
evaluated in the review stage of the software package [28]. A total
of 1200 protein spots were identified across all the samples. Each
spot volume was normalized using the ratiometric method in
Progenesis. The logarithm form of the normalized spot volume
was taken. Differentially expressed protein spots were determined
using analysis of variance (ANOVA) across the two groups (ATCC
and resistant strain). The protein spots with a p-value #0.05 were
considered as significant and those spots were used for subsequent
study [29].
In-Gel Digestion and Peptide Extraction
Protein spots were excised and in-gel digestion was carried out
using trypsin (mass spectrometry grade, Promega Corp., Madi-
son,WI) and peptide were extracted according to manufacture
protocol.
Liquid Chromatography and Electrospray Ionization Mass
Spectrometry (LC-MS/MS)
After digestion, tryptic peptides were analyzed by LC-MS/
MS. The resulting peptide mixture was separated by reverse
phase chromatography (TempoTM nano-LC system, Applied
Biosystems) using a Pep Map C18 column. Peptides were
separated using a 70 minute linear gradient from 5% to 98%
acetonitrile in 0.1% formic acid with a flow rate of 400 nl/min.
The eluting peptides were ionized by electrospray ionization
(ESI) and analysed by QSTAR XL system (Applied Biosystems,
USA). Nanospray ionization was carried out using an ion spray
voltage of 900. The progress of each run was monitored by
recording the total ion current (TIC) for positive ions as a
function of time in the m/z range of 400–1600 for MS and
140–1600 for MS/MS. The spectra was acquired in an
information dependent manner utilizing the Analyst QS 2.0
software acquisition features to generate raw data in the *.wiff
format. The other parameters set were: interface temperature,
Table 1. Selected protein spots from comparative analysis of differentially expressed proteins in DeCyder and Progenesis software.
S.No.
Spot number in
DeCyder (Progenesis)
Fold change In
DeCyder (ANOVA)
Fold change in Progenesis
(ANOVA) Differential Expression
1 490 (213) 7.23 (0.00018) 2.6(0.005) Upregulated
2 904(417) 7.14 (0.00032) 3.4(0.019) Upregulated
3 902 (416) 3.75 (0.00055) 2.7(0.013) Upregulated
4 603 (267) 5.34 (0.0015) 3.7(0.012) Upregulated
5 455(187) 4.95 (0.0017) 3.4(0.001) Upregulated
6 595(265) 3.51 (0.0022) 2.3(0.010) Upregulated
7 428(173) 3.01 (0.0029) 2.9(0.014) Upregulated
8 489 (212) 4.20 (0.0041) 2.2(0.003) Upregulated
9 436 (178) 5.48 (0.0048) 2.5(0.030) Upregulated
10 365 (158) 3.68 (0.0050) 3.7(0.009) Upregulated
11 366 (153) 3.46 (0.0070) 2.7(0.047) Upregulated
12 327 (107) 2.96 (0.0082) 3.0(0.005) Upregulated
13 432 (176) 3.35 (0.0092) 2.9(0.005) Upregulated
14 434 (180) 3.49 (0.028) 2.5(0.011) Upregulated
15 1012 (ND) 4.90 (0.00067) ND Upregulated
16 745 (ND) 2.03 (0.0065) ND Upregulated
17 1089 (ND) 2.96 (0.0010) ND Upregulated
18 645 (ND) 6.50 (0.0017) ND Upregulated
19 650 (ND) 3.74 (0.0010) ND Upregulated
20 945 (420) 26.85 (0.0050) 23.4(0.012) Downregulated
21 1004 (465) 26.28 (0.0053) 27.2(0.002) Downregulated
22 1266(579) 26.37 (0.0054) 22.6(0.017) Downregulated
23 1269(582) 24.79 (0.0077) 22.8(0.010) Downregulated
ND= Not Detected in Progenesis with significant p value ,0.05 and fold change .2.
doi:10.1371/journal.pone.0039451.t001
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60 V; focusing potential, 280 V; declustering potential 2, 15 V.
Database searching was done using Mascot (Matrix Science,
U.K., www.matrixscience.com). Different parameters were
selected during Mascot searching are modifications of methio-
nine (oxidation) and cysteine (carbamidomethylation), charged
state ranging from +1, +2, +3 and search limited to Eubacteria,
peptide mass tolerance range of 1.2 Da and fragment mass
tolerance range of 0.8 Da.
Results and Discussion
ATCC and 25 clinical strains of Acinetobacter were identified as
A. baumannii based on a routine set of biochemical tests [30,22].
MIC of imipenem for all the twenty five clinical strains and a
Figure 1. Differential In-Gel Electrophoresis of inner membrane fraction of Acinetobacter baumannii ATCC19606 and resistant strain
RS307. Up-facing white arrow: Upregulated proteins; Down-facing yellow arrow: Down-regulated proteins.
doi:10.1371/journal.pone.0039451.g001
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Agar dilution method. Details of these resistant strains and their
MICs for imipenem were as follows: ATCC 19606 (MIC;
0.1 mg/ml), 14 strains with MIC; 0.2 to 8 mg/ml, RS030603,
RS8238, RS259, RS117, RS322, RS8031, RS278, RS144,
RS256, RS119, RS336, RS355, RS325 and RS3320, 8 strains
with MIC; .8t o6 4 mg/ml: RS170, RS71, RS122, RS250,
RS398, RS688, RS15368, RS1556 and 3 strains with MIC;
.64 mg/ml: RS168, RS721, RS307. MIC data revealed that 9
of 25 of clinical isolates of A. baumannii were highly resistant
(MIC $64 mg/ml) to imipenem. It was alarming to see a steep
increase to 36% in resistance of A. baumannii as compared to the
incidence of about 20% found five years ago in our hospital [6].
This clearly showed the rise of resistance of A. baumannii to
carbapenems in A.I.I.M.S. Clinical strains with MIC .64 mg/ml
pose a bigger threat (than the rest of the strains) as they are
becoming increasingly resistant. RS307 (MIC, 128 mg/ml) is a
representative of the three clinical strains with high MIC. The
rationale for selecting RS307, is to compare ‘naturally induced’
resistance in RS307 with that of ATCC19606. Comparative
proteomics has been used as an approach to understand the
resistance mechanism in the microorganisms where the ATCC
strain was considered as a reference (susceptible) strain
[31,32,17,11]. We have also performed proteomics of clinical
resistant strains with lower MICs: RS122 with MIC, 32 mg/ml
and RS259 with MIC, 1 mg/ml. However, results showed only
two differentially expressed proteins in each strain (ATP
synthase, DNA protection during starvation protein in RS122
(Table S1) and Elongation factor Tu, 3-isopropyl malate
dehydratase in RS259 (Table S2) respectively).
Differential In-Gel Electrophoresis (DIGE) and Mass
Spectrometry
In the present study, DIGE revealed the presence of about 1200
protein spots in each individual profile of native and RS307 strain
(Figure S1). After DIGE experiments, the data was analysed using
two independent software programs, DeCyder v7.0 (Figure S2)
and Progenesis same spot v3.2 (Figure S3). The rationale behind
using two different programs for the analysis of DIGE data is to
validate the differentially expressed proteins with more authentic-
ity and confidence [28]. However, the difference in the approach
of the two softwares is an added advantage in identifying the
proteins with better accuracy without which some proteins would
have been missed or incorrectly detected.
One would expect that the quantitative changes estimated
between a set of two cross matched protein spots would be the
same or at least similar in terms of fold change by the two
software packages. In fact, the two softwares indeed similarly
Table 2. Identification of differentially expressed proteins of inner membrane fraction of Acinetobacter baumannii resistant strain,
RS307 with reference to ATCC 19606.
Master No. Mw kDa pI Identification and Accession No. Score/% coverage Possible Role in Resistance
Up-regulated Proteins
b-Lactamases
603 43.2 9.49 Beta-lactamase class C [Acinetobacter baumannii]
2::gi|7258342
156/10 AmpC, the major lactamase of class C cleaves
antibiotics.
745 30.6 8.43 Carbapenem-hydrolyzing oxacillinase OXA-71
[Acinetobacter baumannii], gi|57491188
127/8 OXA-71 belongs to OXA-51 oxacillinase and cleaves
oxacillin and other carbapenem.
Proteins associated with metabolism and energy production
455 50.3 5.03 ATP synthase subunit beta OS=Acinetobacter
baumannii (strain ACICU) 1::ATPB_ACIBC
860/48 Make resistant strain more energy efficient by ATP
production.
436 and 434 55.5 5.29 ATP synthase subunit alpha OS=Acinetobacter
baumannii (strain ACICU) 1::ATPA_ACIBC
371/16 Maintain functional conformation of ATP synthase
and help beta subunit to produce ATP
428 42.5 5.64 Dihydrolipoamide dehydrogenase [Acinetobacter
baumannii ATCC 17978] 2::gi|126642748
63/7 Helps with addition energy requirements by
producing acetyl COA.
645 35.4 5.20 Malate dehydrogenase OS=Acinetobacter
baumannii 1::MDH_ACIBC
316/21 Involved in adaptation during oxidative stress and
also in biofilm formation.
432 51.2 5.96 2-oxoglutarate dehydrogenase complex
[Acinetobacter sp. RUH2624] 2::gi|260549007
276/15 Associated with higher oxygen transport and
efficient energy production in resistant strain.
650 38.6 5.27 Coproporphyrinogen III oxidase [Acinetobacter
baumannii SDF]
90/6 Enzyme involved in the porphyrin metabolism, but
its specific role in resistance is unknown.
Protein synthesis machinery
1089 18.0 5.62 50 S Ribosomal protein of Acinetobacter
baumannii RL10_ACIB3
151/16 It activates protein translation to take care of the
increased metabolic requirements.
327 61.3 4.89 30 S ribosomal protein 1::RS1_ECO57 117/2 Elevated ribosomal proteins facilitate carbapenem
resistant.
490 43.2 5.20 Elongation factor Tu [Acinetobacter baumannii]
1::EFTU_ACIBT
138/11 Up regulation of EF-Tu is the consequent event of
ribosome upregulation; promotes translation.
489 43.2 5.20 Elongation factor Tu OS=Acinetobacter sp.
(strain ADP1) 1::EFTU_ACIAD
162/8 Same as above
595 37.3 5.10 DNA-directed RNA polymerase subunit alpha
OS=Acinetobacter baumannii. RPOA_ACIBC
199/14 Activate transcription and thereby protein synthesis
under the antibiotic stress.
Differential expression is shown as fold change (minimum 2 fold, p-value e0.05).
doi:10.1371/journal.pone.0039451.t002
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there is a significant discrepancy in the fold change that is
estimated [28]. Results tabulated in table 1 clearly show that
protein fold changes were substantially different in both
packages, for example, DeCyder and Progenesis has given a
fold change in production of protein S.no:1 as 7.23 and 2.6
respectively. This issue was very elegantly discussed in the recent
technical notes [28], which clearly states that results obtained for
protein fold changes and p-value were substantially different in
Progenesis and DeCyder, which indicates that in spite of using
internal standards, quantification is software dependent [28]. A
glance at Table 1 also tells us that the maximum fold change
detected by DeCyder is much higher ratio (upto 7.23 and 26.85)
as compared to Progenesis Same Spots (3.7 and 27.2). The fold
change of particular spot calculated by the software depends on
the way spot boundaries are defined [28]. Spot detection is
therefore dependent on segmentation of a spot, for example
splitting the same into two or more spots. For example spot 425
was detected as single spot by Progenesis while the same is
detected as multiple spots by DeCyder which often results into
oversplits.
Interestingly, our results reveal that the same proteins were
identified as upregulated proteins and downregulated proteins by
DeCyder and Progenesis, however, only differ in the estimation of
fold change and p-value (see table 1, upregulated 14 spots and
down regulated 4 spots). Although protein spots 15–19 (table 1)
were not detected by Progenesis but were identified by DeCyder
with high significance (p-value and fold change) and therefore can
not be ignored.
Relative production of selected proteins from resistant strain
RS 307 and ATCC 19606 strain is presented in Table 1 and
Figure 1. For the convenience of clearly distinguishing all the
protein spots in figures and throughout the text, we have
designated the proteins and referred them by their master
number from DeCyder. The identified proteins (Figure S4) were
further classified according to their production levels in RS307 as
compared to ATCC; a) upregulated b) down regulated. Most of
the differentially expressed proteins in the carbapenem resistant
strain (present study) are also present in sensitive isolate ATCC
as it is known from the genome database (NCBI) of Acinetobacter
baumannii. The upregulated proteins and their relevance to the
resistance are discussed below.
Upregulated Proteins
The following discussion deals with those proteins whose levels
are relatively high in resistance phenotype RS307. On the basis of
their cellular functions, all the upregulated proteins in RS307 are
associated with: (i) b-lactamase (ii) metabolism and energy
production (iii) protein synthesis machinery and iv) chaperonin.
b-Lactamases. It is well known that b-Lactamases hydrolyze
b-lactam ring and neutralize the effect of antibiotics like
imipenem, penicillin and meropenem etc. b-Lactamases are
produced by Gram negative bacteria as a means of self-defence
against b-lactam antimicrobials; and A. baumannii is no exception.
Class C (AmpC) b-lactamas. Spot no. 603 (43.2 kDa,
9.49 pI) was upregulated by 5.34 fold and identified as class C
(AmpC) b-lactamase of A. baumannii (Table 2). Based on the
recombinant experiments by over expressing AmpC b-lactamase
in K. pneumoniae, Martinez-Martinez et al., found that MIC of
carbapenems indeed increased significantly from 1 to 64 mg/ml in
the recombinant organism harbouring AmpC b-lactamase gene
and loss of porins [33]. Further, a report from France also
demonstrates the emergence of peculiar AmpCs (ADCs) in the
hospital isolates of A. baumannii and their role in broad spectrum
Table 3. Identification of differentially expressed proteins of inner membrane fraction of Acinetobacter baumannii resistant strain,
RS307 with reference to ATCC 19606.
Master No. Mw kDa pI Identification and Accession No. Score/% coverage Possible Role in Resistance
Up-regulated Proteins
Chaperonins
365 57.2 4.92 60 kDa chaperonin OS=Acinetobacter baumannii
(strain AB307-0294) 1::CH60_ACIB3
191/11 Maintain newly translated protein in the
correctly folded form.
366 31.7 4.74 TCP-1/cpn60 chaperonin family protein
2::gi|254480295
62/20 Involved in stress induced stabilisation of
protein. It also protects disassembled
polypeptides under heat-shock conditions.
Transporter
1012 16.4 4.79 Putative lipoprotein [Acinetobacter baumannii
SDF] 2::gi|169633901
236/36 Lipoproteins have been implicated in the
adhesion and translocation of virulence factors
in host cells.
Unknown function
902 and 904 26.4 4.79 Carbapenem-associated resistance protein
precursor [Acinetobacter baumannii]
2::gi|56131242
283/19 Known to be involved in carbapenem
resistance- direct function is unknown
Down-regulated Proteins
1266 and 1269 11.3 4.77 Surface antigen [Acinetobacter baumannii ATCC
17978] 2::gi|126641429
75/11 Evade host defense mechanism and decrease
cellular recognition by host.
945 20.7 5.66 Ribosome-recycling factor OS=Acinetobacter
baumannii (strain SDF) RRF_ACIBT
75/8 Associated with increase in the efficiency of
translation.
1004 21.2 5.56 Putative outer membrane protein W
[Acinetobacter baumannii ] 2::gi|239500971
53/10 Decreased entry of antibiotic.
Differential expression is shown as fold change (minimum 2 fold, p-value e0.05).
doi:10.1371/journal.pone.0039451.t003
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due to the presence of the insertion sequence ISAba1 upstream to
AmpC gene [35]. These reports are in full agreement with the
present finding of elevated levels of AmpC in the RS 307 of
A. baumannii which directly correlates with increased resistance to
carbapenem.
OXA-71/OXA-51, a class D b-lactamase. The other b-
lactamase which has been found to be upregulated in RS 307 was
the protein spot no.745 which has Mol. Wt. 30.6 kDa and a pI of
8.48. Mass spectrometry identified it as OXA-71, a class D b-
lactamase of A. baumannii (Table 2). OXA-71 has 99% similarity
with OXA-51 of A. baumannii [36]. The over-production of the
OXA-51 is an interesting observation from the present study.
Presence of different variants of OXA was reported in imipenem
resistant A. baumannii in different parts of the world- India [36],
Argentina [37], Taiwan [7] and Brazil [38]. A hospital study from
Taiwan has shown that high load of OXA-51 could predict the
mortality of patients suffering from A. baumannii bacteremia [7].
Similarly, Costa et. al. reported that presence of OXA-23 in
A. baumannii confers resistance to most b-lactams including
imipenem, aztreonam and Ceftazidime [38]. Figueiredo et al.
reported that overexpression of OXA b-lactamase gene is
mediated by the presence of insertion sequence ISAba in OXA
gene [39,40]. Therefore, it is explicit that OXAs carrying
A. baumannii are increasingly becoming endemic.
Proteins associated with metabolism and energy
production. Increased metabolic activity and energy produc-
tion are required for pathogen to resist high antibiotics load/stress
[20,41]. Metabolic enzymes are reported to be present in the inner
membrane fraction [17,20,24,42,43]. The metabolic changes may
be a consequence of the biological cost of antibiotic resistance
Figure 2. Schematic presentation of upregulated (q) and downregulated (Q) proteins in the carbapenem-resistant A. baumannii.
doi:10.1371/journal.pone.0039451.g002
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ATP synthase. DeCyder analysis showed that spot 455
(50.3 kDa and 5.0 pI) was upregulated by 4.95 fold and been
identified as beta subunit of ATP synthase which is crucial for
ATP synthesis (Table 2). This is supported by the findings of Lee et
al., where the authors have noticed increased production of beta-
subunit of ATP synthase when A. baumannii cultures were grown
containing imipenem (32 mg/ml) [30]. It may be mentioned here
that besides ATP synthase, Lee et al., also found some more
induced proteins in A. baumannii, which will be discussed in sequel.
Identification of upregulated proteins, spot no. 436 and 434 as
ATP synthase subunit alpha (55.5 kDa, 5.29 pI) (Table 2) suggests
their important role in maintaining functional conformation of F1
subunit of ATP synthase. Based on 2D-DIGE, Santos et al., has
shown that piperacilln-induced resistance strain of E. coli showed
elevated levels of ATP synthase [45]. All these suggest the
activation of energy efficient mechanism by the bacteria as a
means of survival.
Dihydrolipoamide dehydrogenase. Spot no. 428 (42.5 kDa
and 5.64 pI) was found to be upregulated by 3.01 fold and was
identified as dihydrolipoamide dehydrogenase of A. baumannii
(Table 2). Dihydrolipoamide dehydrogenase provides acetyl-CoA
required for TCA cycle and biosynthesis of fatty acids. High levels
of dihydrolipoamide dehydrogenase was also reported in several
other microorganisms like antimicrobial peptide-resistant Vibrio
parahaemolyticus [46], toluene-resistant Pseudomonas putida [47] and
tellurite- resistant E. coli [48]; suggesting the need of the enzyme
for addition energy requirement in survival.
Malate dehydrogenase. Protein spot no. 645 was upregu-
lated by 6.5 fold and identified as malate dehydrogenase of
A. baumannii with Mol. Wt. of 35.4 kDa and pI of 5.2 (Table 2).
Malate dehydrogenase being a part of TCA cycle (which acts as
anapleurotic cycle) is important for energy production. Increased
levels of malate dehydrogenase is an attempt to overcome the
oxidative stress as seen in E. coli [49,48], during the adaptation
from anaerobic to aerobic conditions and also in the biofilm
formation in A. baumannii [21].
Enzymes involved in porphyrin synthesis. Two protein
spots 432 and 650 were identified as 2-oxoglutarate dehydroge-
nase complex and coproporphyrinogen III oxidase of Acinetobacter
respectively (Table 2) and are known to have a role in porphyrin
synthesis. However, it has been suggested that increased produc-
tion of prophyrin helps in oxidative phosphorylation in E. coli [50].
Protein synthesis machinery. It has been seen that under
stress conditions like antibiotics, the microorganism activate the
protein synthesis so as to take care of the increased metabolic
requirements. Supporting this phenomenon in RS 307 of
A. baumannii, we report the upregulation of 30 S, 50 S ribosomal
proteins and elongation factor Tu (EF-Tu) which are part of the
protein synthesis machinery (Table 2). Recently, these proteins are
reported in membrane fraction of A. baumannii [17,20] and other
negative bacteria [51]. Because of their critical role in resistance,
they have been chosen as the target for a number of antibiotics
against gram negative bacteria [52]. The increased production of
ribosomal proteins in the clinical strain may be one of the ways by
which organism tries to counterbalance the effect of antibiotics.
Upregulation of EF-Tu is the consequent event of upregulated
30 S and 50 S ribosome and promotes translation. Yun et al., also
report elevated ribosomal proteins in the carbapenem resistant
strain of A. baumannii [20] High copy number of mRNA is another
factor which increases the protein synthesis. Elevated levels (fold
change 3.5) of the alpha subunit of DNA-directed RNA
polymerase, (spot 595) suggests the overall activation of transcrip-
tion and thereby protein synthesis under the antibiotic stress in
A. baumannii.
Chaperonin required to maintain native conformation of
proteins. As explained above, overall protein synthesis related
proteins were more abundant in resistant bacteria and it is also
known the protein after synthesis is brought into its native, active
conformation by the group of proteins, ‘‘chaperonins’’. Chaper-
orins are usually found in the cytosol but there are reports which
have shown the presence of chaperonins in the inner membrane
fraction [17,53]. This suggests that there is an increased need of
chaperonins in resistance [54], in order to maintain the newly
translated protein in the correctly folded form. This is exactly what
is observed in RS 307 of A. baumannii, which increased the
production of two, 60 kDa chaperonin (spot no 365) and TCP-1/
cpn60 chaperonin family protein (spot no. 366) of A. baumannii
(Table 3) under carbapenem stress. It suggests the requirement of
efficient folding machinery in the carbapenem-resistant strain. Lee
et al., found that cpn60 chaperonin was elevated in the hetero-
resistance A. baumannii under imipenem induction [30].
Putative lipoprotein. Transporters as the name suggests,
supply of nutrients/ions/metabolites and required for survival of
the microorganism. We found high concentration (4.9 fold) of one
such transporter of lipid, putative lipoprotein (spot no. 1012) with
mol. wt. of 16.4 kDa (Table 3). In Gram-negative bacteria, mature
lipoproteins are localized to various sites within the cell wall. They
are targeted to the periplasmic face of the inner or outer
membranes by the lipoprotein localization machinery [55]. Hence
it is possible for lipoproteins to be present in the inner membrane
fraction at the time of isolation from A. baumannii. Thus lipoprotein
could be used to generate novel countermeasures to infections
caused by A. baumannii.
Unknown proteins. Further, two other protein spots, 902
and 904 (26.4 kDa, 4.79 pI) which were identified as the
carbapenem-associated resistance protein precursor of Acinetobacter
baumannii (Table 3). Function of this precursor is unknown in
A. baumannii.
Downregulated Proteins
In addition, A. baumannii also changes the protein production of
several other proteins so as to evade the host defence mechanism.
Surface antigens. Two such protein spots no. 1266 and
1269 were found to be diminished by 6.37 and 4.79 respectively
and have been identified as surface antigen of A. baumannii
(Table 3). Surface antigen on the membrane of gram negative
bacteria is recognised by host defence mechanism. Cell surface
antigens are involved in cellular recognition processes by
antibodies produced by host against bacteria hence either down
regulation or modification of surface antigen is advantageous for
pathogenic bacteria [56].
Ribosome-recycling factor. As the name suggests ribo-
some-recycling factor is involved in recycling of ribosome by
splitting ribosome into 50 S and 30 S subunits. The lower levels of
this protein increase translation of mRNA. However, in the
present study, it was found that the resistant strain of A. baumannii
suppressed (by 6.8 fold) the production of ribosome recycling
factor.
OmpW. OmpW is an outer membrane protein and it was
recently proposed that OmpW of A. baumannii is involved in the
uptake of antibiotics like colistin and b-lactams (ceftriaxone) [16].
Although it is surprising to find OmpW in the inner membrane
fraction, there are such reports in the past where OmpW is seen in
periplasmic space [20]. Decreased production of OmpW (spot
no 1004) by 6.23 fold in b-lactam- resistant A. baumannii, RS307
(Table 3), is in agreement with earlier reports in colistin-resistant
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ium [57,16]. Hence decreased OmpW perhaps reduces entry of b-
lactams in the A. baumannii and makes b-lactams unavailable to its
target (PBPs).
Conclusions
Acquired resistance to carbapenem, in A. baumannii is a
multifactorial phenomenon in which the bacterium applies a
number of intricate and robustic means to evade the antimicrobial
effect of antibiotic. Increased production of b-lactamases to cleave
the antibiotic is the first step in developing resistance. It appears
that A. baumannii employs efficient and robust metabolic mecha-
nisms by increasing the production of metabolic enzymes, as is
evident from the present data. It is tempting to speculate that,
elevated levels of ribosomal proteins and chaperonin may help in
rapid translation and proper folding of metabolic enzymes
respectively. In addition, A. baumannii down regulates a number
of proteins like surface antigen which assist in evading host defence
mechanism. In conclusion, A. baumannii seems to apply a number
of ways which work cooperatively and synergistically which help in
developing resistance to antibiotic in clinical strain with respect to
reference strain. Present finding are schematically summarized in
Figure 2.
Supporting Information
Figure S1 Differential In-Gel Electrophoresis (DIGE)
results of RS307 and ATCC19606.
(PDF)
Figure S2 DeCyder analysis of RS307 DIGE results.
(PDF)
Figure S3 Progenesis analysis of RS307 DIGE results.
(PDF)
Figure S4 Mascot search results for differentially
expressed proteins in inner membrane fraction of
RS307.
(PDF)
Table S1 Differentially expressed proteins identified in
inner membrane fraction of RS122.
(PDF)
Table S2 Differentially expressed proteins identified in
inner membrane fraction of RS259.
(PDF)
Author Contributions
Conceived and designed the experiments: RRM. Performed the experi-
ments: VT. Analyzed the data: VT RRM. Contributed reagents/
materials/analysis tools: RRM AK JV. Wrote the paper: VT RRM.
References
1. Maragakis LL, Perl TM (2008) Acinetobacter baumannii: epidemiology, antimicro-
bial resistance, and treatment options. Clin Infect Dis 46:1254–1263.
2. Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of
multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8: 751–
762.
3. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez
FJ, Perez-Paredes C (2001) Risk factors for Acinetobacter baumannii nosocomial
bacteremia in critically ill patients: a cohort study. Clin Infect Dis 33: 939–946.
4. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez
FJ, Monterrubio-Villar J (1999) Mortality and the increase in length of stay
attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care
Med 27: 1794–1799.
5. Suri A, Mahapatra AK, Kapil A (2000) Acinetobacter infection in neurosurgical
intensive care patients. Natl Med J India 13: 296–300.
6. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, et al. (2006) Emerging
resistance to carbapenems in a tertiary care hospital in north India. Indian J Med
Res 124 (1): 95–8.
7. Chuang YC, Chang SC, Wang WK (2010) High and increasing Oxa-51 DNA
load predict mortality in Acinetobacter baumannii bacteremia: implication for
pathogenesis and evaluation of therapy. PLoS ONE 5(11): e14133.
8. Falagas ME, Kopterides P, Siempos I (2006) Attributable mortality of
Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis 43:
389–390.
9. Fishbain J, Peleg AY (2010) Treatment of Acinetobacter infections. Clin Infect Dis
51: 79–84.
10. Vila J, Pachon J (2008) Therapeutic options for Acinetobacter baumannii infections.
Expert Opin Pharmacother 9(4): 587–99.
11. Vashist J, Tiwari V, Kapil A, Rajeswari MR (2010) Quantitative profiling and
identification of outer membrane proteins of b-Lactam resistant strain of
Acinetobacter baumannii. J Proteome Res 9:1121–1128.
12. Vashist J, Tiwari V, Das R, Kapil A, Rajeswari MR (2011) Analysis of penicillin-
binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii.
Indian J Med Res 133: 332–338
13. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a
successful pathogen. Clin Microbiol Rev 21: 538–582.
14. Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, Ayala JA, Perea EJ, et
al. (2003) Relationship between b-lactamase production, outer membrane
protein and penicillin-binding protein profiles on the activity of carbapenems
against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemoth 51: 565–
74.
15. Kohlenberg A, Brummer S, Higgins PG, Sohr D, Piening BC, et al. (2009)
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbape-
nemase OXA-23 in a German university medical centre. J Med Microbiol
58:1499–1507.
16. Vila J, Mart S, Sanchez-Cespedes J (2007) Porins, efflux pumps and multidrug
resistance in Acinetobacter baumannii. J Antimicrob Chemoth 59:1210–1215.
17. Siroy A, Costette P, Seyer D, Lemaitra-Guillier C, Vallent D, et al. (2006)
Global comparison of the membrane subproteomes between a multidrug
resistant Acinetobacter baumannii strain and a reference strain. J Proteome Res 5:
3385–3398.
18. Siroy A, Molle V, Lemaitre-Guillier C, Vallent D, Pestelcaron M, et al. (2005)
Channel formation by CarO, the carbapenem resistance-associated outer
membrane protein of Acinetobacter baumannii. Antimicrob Agents Chemother 49:
4876–83.
19. Fernandez-Reyes M, Rodriguez-Falcon M, Chiva C, Pachon J, Andreu D, et al.
(2009) The cost of resistance to colistin in Acinetobacter baumannii: a proteomic
perspective. Proteomics 9: 1632–45.
20. Yun SH, Choi CW, Kwon S, Park GW, Cho K, et al. (2011) Quantitative
proteomic analysis of cell wall and plasma membrane fractions from multidrug
resistant Acinetobacter baumannii. J Proteome Res 10 (2): 459–69.
21. Shin JH, Lee HW, Kim SM, Kim J (2009) Proteomic analysis of Acinetobacter
baumannii in biofilm and planktonic growth mode. J Microbiol 47(6): 728–35.
22. Constantiniu S, Romaniuc A, Iancu LS, Filimon R, Taras ¸i I (2004) Cultural and
biochemical characteristics of Acinetobacter spp. strains isolated from hospital units.
J Prevent Med 12: 35–42.
23. Filip C, Fletcher G, Wulff JL, Earhart CF (1973) Solubilization of the
cytoplasmic membrane of Escherichia coli by the ionic detergent sodium lauryl
sarcosinate. J Bacteriol 115 (3): 717–722.
24. Pieper R, Huang S, Clark DJ, Robinson JM, Alami H, et al. (2009) Integral and
peripheral association of proteins and protein complexes with Yersinia pestis inner
and outer membranes. Proteome Sci 7:5.
25. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, et al.(2003) A novel
experimental design for comparative two-dimensional gel analysis: two-
dimensional difference gel electrophoresis incorporating a pooled internal
standard. Proteomics 3(1): 36–44.
26. Alteri CJ, Mobley HLT (2007) Quantitative profile of the uropathogenic
Escherichia coli outer membrane proteome during growth in human urine. Infect
Immun 75 (6): 2679–2688.
27. Bisle B, Schmidt A, Scheibe B, Klein C, Tebbe A, et al. (2006) Quantitative
profiling of the membrane proteome in a halophilic archaeon. Mol Cell
Proteomics 5 (9): 1543–1558.
28. Kang Y, Techanukul T, Mantalaris A, Nagy JM (2009) Comparison of three
commercially available DIGE analysis software packages: minimal user
intervention in gel-based proteomics. J Proteome Res 8 (2): 1077–1084.
29. Fan Y, Murphy TB, Byrne JC, Brennan L, Fitzpatrick JM (2011) Applying
random forests to identify biomarker panels in serum 2D-DIGE data for the
detection and staging of prostate cancer. J Proteome Res 10: 1361–1373.
30. Lee H, Chenb C, Wangb S, Sud L, Chenb S, et al. (2011) Imipenem
heteroresistance induced by imipenem in multidrug-resistant Acinetobacter
baumannii: mechanism and clinical implications. Int J Antimicrob Agents 37:
302–308.
Proteomics of Membrane Fraction of A. baumannii
PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e3945131. Santos KV, Carvalho MA, Martins WA, Andrade HM, Veloso LC, et al. (2011)
Phenotypic changes in a laboratory-derived ertapenem-resistant Escherichia coli
strain. J Chemother 23(3):135–9.
32. Seneviratne CJ, Wang Y, Jin L, Abiko Y, Samaranayake LP (2010) Proteomics
of drug resistance in Candida glabrata biofilms. Proteomics 10:1444–1454.
33. Martı ´nez-Martı ´nez L, Pascual A, Herna ´ndez-Alle ´s S, Alvarez-Dı ´az D, Sua ´rez
AI, et al. (1999) Roles of b-Lactamases and porins in activities of carbapenems
and cephalosporins against Klebsiella pneumonia. Antimicrob Agents Chemother
43(7): 1669–1673.
34. Rodrı ´guez-Martı ´nez J, Poirel L, Nordmann P (2010) Genetic and functional
variability of AmpC-Type b-Lactamases from Acinetobacter baumannii. Antimicrob
Agents Chemother 54 (11): 4930–4933.
35. Heritier C, Poirel L, Nordmann P (2006) Cephalosporinase over-expression
resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Micro Infect
12(2): 123–130.
36. Tiwari V, Kapil A, Moganty RR (2012) Carbapenem-hydrolyzing Oxacillinase
in high resistant strains of Acinetobacter baumannii isolated from India. Microb
Pathogenesis: In press (DOI: 10.1016/j.micpath.2012.05.004).
37. Brown S, Young H K, Amyes SGB (2005) Characterisation of OXA-51, a novel
class D carbapenemase found in genetically unrelated clinical strains of
Acinetobacter baumannii from Argentina. Clin Microbiol Infect 11: 11–5.
38. Costa L, Coelho MJM, Souza HAPHM, Castro MES, Stier CJN, et al. (2003)
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23
enzyme in Curitiba, Brazil. J Clin Microbiol 41:3403–3406.
39. Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P (2009)
Overexpression of the naturally occurring blaOXA-51 Gene in Acinetobacter
baumannii Mediated by Novel Insertion Sequence ISAba9. Antimicrob Agents
Chemother 53(9):4045–4047.
40. Figueiredo S, Poirel L, Croize J, Recule C, Nordmann P (2009) In Vivo selection
of reduced susceptibility to carbapenems in acinetobacter baumannii related to
ISAba1-mediated overexpression of the natural blaOXA-66 oxacillinase gene.
Antimicrob Agents Chemother 53(6): 2657–2659.
41. Madeira A, Santos PM, Coutinho CP, Pinto-de-Oliveira A, Sa-Correia I (2011)
Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by
Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under
antimicrobial therapy. Proteomics 11:1313–1328.
42. Stenberg F, Chovanec P, Maslen SL, Robinson CV, Ilag LL, et al. (2005)
Protein complexes of the Escherichia coli cell envelope. J Bio Chem 280(41):
34409–34419.
43. Marti S, Sanchez-Cespedes J, Oliveira E, Bellido D, Giralt E, et al. (2006)
Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter
baumannii. Proteomics 6: S82-S87.
44. Soares NC, Cabral MP, Parreira JR, Gayoso C, Barba MJ, et al. (2009) 2-DE
analysis indicates that Acinetobacter baumannii displays a robust and versatile
metabolism. Proteome Sci 7:37.
45. Santos KV, Diniz CG, Veloso LC, Andrade HM, Giusta MS, et al. (2010)
Proteomic analysis of Escherichia coli with experimentally induced resistance to
piperacillin/tazobactam. Res Microbiol 161:268–275.
46. Shen CJ, Kuo TY, Lin CC, Chow LP, Chen WJ (2010) Proteomic identification
of membrane proteins regulating antimicrobial peptide resistance in Vibrio
parahaemolyticus. J Appl Microbiol 108(4):1398–407.
47. Kim K, Lee S, Lee K, Lim D (1998) Isolation and characterization of toluene-
sensitive mutants from the toluene-resistant bacterium Pseudomonas putida GM73.
J Bacteriol 180(14): 3692–3696.
48. Castro ME, Molina RC, Dı ´az WA, Pradenas GA, Va ´squez CC (2009)
Expression of Aeromonas caviae ST pyruvate dehydrogenase complex components
mediate tellurite resistance in Escherichia coli. Biochem Biophys Res Commun
380: 148–152.
49. Echave P, Tamarit J, Cabiscol E, Ros J (2003) Novel antioxidant role of alcohol
dehydrogenase from Escherichia coli. J Biol Chem 278(32): 30193–30198.
50. Breckau D, Mahlitz E, Sauerwald A, Gunhild L, Dieter J (2003) Oxygen-
dependent coproporphyrinogen III oxidase (HemF) from Escherichia coli is
stimulated by manganese. J Biol Chem 278(47): 46625–46631.
51. Nieves W, Heang J, Asakrah S, Bentrup KH, Roy CJ, et al. (2010)
Immunospecific responses to bacterial elongation factor Tu during Burkholderia
infection and immunization. PLoS ONE 5(12): e14361.
52. Harms JM, Bartels H, Schlu ¨nzen F, Yonath A (2003) Antibiotics acting on the
translational machinery. J Cell Sci 116: 1391–1393.
53. Garduno RA, Chong A, Nasrallah GK, Allan DS (2011) The Legionella
pneumophila chaperonin- an unusual multifunctional protein in unusual locations.
Front Microbiol 2:122.
54. Cardoso K, Gandra RF, Wisniewski ES, Osaku CA, Kadowaki MK, et al.
(2010) DnaK and GroEL are induced in response to antibiotic and heat shock in
Acinetobacter baumannii. J Med Microb 59: 1061–1068.
55. Kovacs-Simon A, Titball RW, Michell SL (2011) Lipoproteins of bacterial
pathogens. Infect Immun 79(2): 548–561.
56. Nikaido H (1999) Microdermatology: Cell surface in the interaction of microbes
with the external world. J Bacteriol 181 (1): 4–8.
57. Hong H, Patel DR, Tamm LK, Berg B (2006) The outer membrane protein
OmpW forms an eight-stranded b-Barrel with a hydrophobic channel. J Biol
Chem 281(11): 7568–7577.
Proteomics of Membrane Fraction of A. baumannii
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e39451